Tiffany Eul Davis Inglis

CIK: 0002091798

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)3 (60.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (40.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

SERA

SERA PROGNOSTICS, INC.

Officer

Discretionary Trading P&L

Holdings

Transaction History (5 total)

SERA
SERA PROGNOSTICS, INC.
Oct 12, 2026
Sale(S)
Direct
8K shares at avg. $2.03$16K
SERA
SERA PROGNOSTICS, INC.
Sep 10, 2026
Sale(S)
Direct
486 shares at avg. $2.00$972
SERA
SERA PROGNOSTICS, INC.
Jun 11, 2026
Sale(S)
Direct
362 shares at avg. $2.01$727.62
SERA
SERA PROGNOSTICS, INC.
Mar 12, 2026
Award(A)
Direct
17.4K shares-
SERA
SERA PROGNOSTICS, INC.
Oct 15, 2025
Award(A)
Direct
75K shares-

		Type	Shares	Price		Ownership
Oct 12, 2026	SERA SERA PROGNOSTICS, INC.	Sale(S)	8,024	$2.03	$16,289	Direct
Sep 10, 2026	SERA SERA PROGNOSTICS, INC.	Sale(S)	486	$2.00	$972	Direct
Jun 11, 2026	SERA SERA PROGNOSTICS, INC.	Sale(S)	362	$2.01	$728	Direct
Mar 12, 2026	SERA SERA PROGNOSTICS, INC.	Award(A)	17,437	-	$0	Direct
Oct 15, 2025	SERA SERA PROGNOSTICS, INC.	Award(A)	75,000	-	-	Direct

1-5 of 5 transactions

About Inglis Tiffany Eul Davis

Inglis Tiffany Eul Davis (SEC CIK 0002091798) files insider reports with the SEC as Chief Medical Officer of SERA PROGNOSTICS, INC. (SERA).

Signal8 holds 6 ownership filings by Inglis Tiffany Eul Davis (1 Form 3, 5 Form 4), filed between Oct 15, 2025 and Oct 13, 2026. Those filings report 5 transactions, from Oct 15, 2025 to Oct 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Inglis Tiffany Eul Davis's filings is in SALT LAKE CITY, UT.

Recent filings by Inglis Tiffany Eul Davis

Oct 12, 2026: Open-market sale of SERA shares (Form 4, code S).
Sep 10, 2026: Open-market sale of SERA shares (Form 4, code S).
Jun 11, 2026: Open-market sale of SERA shares (Form 4, code S).
Mar 12, 2026: Grant or award of SERA shares (Form 4, code A).
Oct 15, 2025: Grant or award of SERA shares (Form 4, code A).

Other insiders filing for SERA PROGNOSTICS, INC. (SERA)

Anderson Dyaarl Lee Jr., Chief Commercial Officer
Lindgardt Zhenya, Chief Executive Officer
Jackson Benjamin, General Counsel
Aerts Austin, Chief Financial Officer
Gleason Scott, Chief Financial Officer
Phillips Joshua, Director

How to read Form 4 transaction codes